Udhayvir Grewal, Resident Physician at Ochsner LSU Health Shreveport Academy Medical Centre, shared a post on X:
“Excited to share our new review in npj Journals Precision Oncology: ‘Mucin-1: A Promising Pan-Cancer Therapeutic Target’
We discuss:
- How aberrant MUC1 expression and glycosylation drive oncogenesis in solid and hematologic cancers
- The pipeline of MUC1-targeted therapies — including vaccines, CAR-T cells, ADCs, radiopharmaceuticals, and bispecifics
- Key challenges with first-generation agents and what’s ahead for MUC1.
Thank you Dr. Razelle Kurzrock for your mentorship and guidance in helping bring this work to life.”
Title: Mucin-1: a promising pan-cancer therapeutic target
Authors: Udhayvir Singh Grewal and Razelle Kurzrock
You can read the Full Article on npj Precision Oncology
More posts featuring Udhayvir Grewal.
